Development of a stable low-dose aglycosylated antibody formulation to minimize protein loss during intravenous administration.

Morar-Mitrica, Sorina

Development of a stable low-dose aglycosylated antibody formulation to minimize protein loss during intravenous administration. [electronic resource] - mAbs 2015 - 792-803 p. digital

Publication Type: Journal Article

1942-0870

10.1080/19420862.2015.1046664 doi


Administration, Intravenous
Animals
Antibodies, Monoclonal, Humanized--chemistry
CHO Cells
Cricetinae
Cricetulus
Drug Compounding
Drug Stability
Humans
Immunoglobulin G--chemistry
Protein Stability